GHK-Cu: Preclinical Research Overview
What is GHK-Cu?
GHK-Cu (also called copper-tripeptide-1) is a peptide — a short chain of amino acids, the building blocks that make up proteins. This one is made of just 3 of those building blocks (glycine, histidine and lysine), so it is called a tripeptide ("tri" means three). It is joined to a single copper ion, which is what the "Cu" stands for (Cu is the chemical symbol for copper). The "Cu" copper part is why scientists call it GHK-Cu. It was first found in human blood plasma (the liquid part of blood) in the 1970s by two researchers, Pickart and Thaler. In lab dish tests, they saw it could change how liver cells from older donors behaved.[1]
The amount of GHK in our blood drops as we get older. That is one reason scientists keep studying it as a research tool in models of tissue repair (the body fixing damage), skin-cell biology, and antioxidant pathways (the systems that mop up cell-damaging particles). The lab-made version used for research is chemically the same as the natural one, with the copper part still attached.
Mechanisms Studied in Preclinical Research
In lab-dish (in vitro) and animal studies, GHK-Cu has been linked to several body pathways — the chains of signals cells use to do their jobs. The points below are things researchers have observed in studies only, not effects in people.
Collagen & elastin gene expression
In studies on skin cells called dermal fibroblasts (the cells that build the support structure of skin), GHK-Cu was linked to switching on genes for type I collagen, elastin, decorin and glycosaminoglycans. These are the materials that give skin and other connective tissue its strength and stretchiness. (A gene being "expressed" just means the cell is using its instructions to make that material.)[2]
Antioxidant & copper-transport activity
GHK-Cu is studied as a tool for looking at how copper moves around inside tissue, and for how it relates to antioxidant enzymes (proteins like superoxide dismutase that help mop up cell-damaging particles) in lab tests where cells are put under oxidative stress.[3]
Wound-response & angiogenesis models
In rodent and lab-dish studies that mimic how tissue heals, GHK-Cu has been observed alongside angiogenesis (the growing of new blood vessels), the movement of skin-building fibroblast cells, and the rebuilding of the tissue's support structure — all common things scientists measure in repair research.[4]
Key Research Literature
GHK-Cu has been studied since the 1970s, with the bulk of the modern preclinical literature originating from the research group of Loren Pickart and collaborators, with additional work from Maquart and others. Selected representative work:
Summaries above are derived from publicly available peer-reviewed literature and describe research observations only. They are not claims of efficacy or safety in humans.
Handling in the Laboratory
Velox GHK-Cu comes as a lyophilised (freeze-dried) powder with the copper part still attached. The copper gives it a deep-blue colour, which is normal for this compound. For lab use, you reconstitute it (mix the powder back into a liquid) using bacteriostatic water (sterile water with a tiny amount of preservative to stop germs growing). Our reconstitution calculator helps you work out the right amounts.
- Lyophilised storage: −20°C, dry and dark.
- Reconstituted storage: 2–8°C; avoid freeze–thaw cycles; protect from light.
- Verification: every batch is third-party HPLC-tested; batch documentation available on request.
References
- Pickart L — foundational identification and characterisation of GHK and its copper complex; multiple journals. PubMed.
- Maquart F-X, et al. — GHK-Cu and matrix glycosaminoglycan / collagen expression in dermal fibroblast research. PubMed.
- Pickart L, Margolina A — reviews of GHK and gene-expression / antioxidant pathway research. PubMed.
- Research examining GHK-Cu in angiogenesis, fibroblast migration and matrix remodelling models. PubMed.
Frequently Asked Questions
What is GHK-Cu?
GHK-Cu (copper-tripeptide-1) is a naturally-occurring tripeptide (glycyl-L-histidyl-L-lysine) complexed with a copper(II) ion. It was originally isolated from human plasma in the 1970s and has been studied since in tissue-remodelling, dermal-fibroblast and antioxidant-pathway research. It is supplied by Velox Peptides for in vitro research use only.
What pathways has GHK-Cu been studied in?
Preclinical literature has examined GHK-Cu in relation to collagen and elastin gene expression in dermal fibroblasts, antioxidant enzyme activity (including superoxide dismutase) and copper trafficking, angiogenic signalling and fibroblast migration in wound-response models. These describe research observations only — not therapeutic effects.
What purity is Velox Peptides GHK-Cu?
Velox Peptides GHK-Cu is HPLC-verified at ≥99% purity, with the copper centre intact. Batch documentation is available on request — email veloxpeps@gmail.com to request a copy prior to ordering.
Is GHK-Cu legal to buy in the UK?
GHK-Cu is supplied strictly as a research reagent for in vitro research purposes, in accordance with our Research Use Policy. It is not a licensed medicine and is not approved for human use — not for human or veterinary consumption.
What form does Velox Peptides GHK-Cu come in?
GHK-Cu is supplied as lyophilised (freeze-dried) deep-blue powder (the characteristic colour of the Cu(II) complex). It is reconstituted with bacteriostatic water before use; our reconstitution calculator can assist with concentration calculations. Store reconstituted solutions at 2–8°C, protected from light.